Literature DB >> 32082470

Acral Myxoinflammatory Fibroblastic Sarcoma: Report of a Case and Treatment with Mohs Micrographic Surgery.

Marcella Leal Novello D'Elia1,2,3, Kelly K Park1,2,3, Eduardo Weiss1,2,3.   

Abstract

Acral myxoinflammatory fibroblastic sarcoma (AMFS) represents a low-grade sarcoma with a high rate of local recurrence that commonly affects the distal extremities. The lesion often presents as a painless mass in the hands or feet. There is no formal standardized treatment protocol for this tumor, but wide surgical excision, with or without adjuvant radiation therapy, is the conventional treatment. We report a case of a patient with an AMFS treated with Mohs micrographic surgery (MMS) without recurrence. Because of the propensity of this tumor to involve acral sites where tissue conservation is important, MMS might be an alternative treatment modality for this rare entity.
Copyright © 2020. Matrix Medical Communications. All rights reserved.

Entities:  

Keywords:  Acral myxoinflammatory fibroblastic sarcoma; Mohs micrographic surgery; radiation

Year:  2020        PMID: 32082470      PMCID: PMC7028376     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN: 1941-2789


  6 in total

1.  Acral myxoinflammatory fibroblastic sarcoma successfully treated using Mohs micrographic surgery.

Authors:  Yvette A Tivoli; Jacqueline A Thomas; Andrea F Chen; Eduardo T Weiss
Journal:  Dermatol Surg       Date:  2013-10-14       Impact factor: 3.398

2.  Management of acral myxoinflammatory fibroblastic sarcoma.

Authors:  Ajay Tejwani; Wendy Kobayashi; Yen-Lin Evelyn Chen; Andrew E Rosenberg; Sam Yoon; Kevin A Raskin; Daniel I Rosenthal; Gunnlaugur P Nielsen; Francis J Hornicek; Thomas F Delaney
Journal:  Cancer       Date:  2010-08-24       Impact factor: 6.860

3.  Acral myxoinflammatory fibroblastic sarcoma.

Authors:  H Chahdi; A Damiri; M Oukabli; A Albouzidi; S Bouabid; K Lazrek
Journal:  Orthop Traumatol Surg Res       Date:  2010-06-26       Impact factor: 2.256

4.  High-grade myxoinflammatory fibroblastic sarcoma: a report of 23 cases.

Authors:  Michael Michal; Dmitry V Kazakov; Ladislav Hadravský; Zdeněk Kinkor; Naoto Kuroda; Michal Michal
Journal:  Ann Diagn Pathol       Date:  2015-04-06       Impact factor: 2.090

5.  Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma.

Authors:  Aileen M Davis; Brian O'Sullivan; Robert Turcotte; Robert Bell; Charles Catton; Pierre Chabot; Jay Wunder; Alex Hammond; Veronique Benk; Rita Kandel; Karen Goddard; Carolyn Freeman; Anna Sadura; Benny Zee; Andrew Day; Dongsheng Tu; Joseph Pater
Journal:  Radiother Oncol       Date:  2005-04       Impact factor: 6.280

6.  Acral myxoinflammatory fibroblastic sarcoma: A case report and literature review.

Authors:  Andrew G Silver; Richard C Baynosa; Raman C Mahabir; Wei Z Wang; William A Zamboni; Kayvan T Khiabani
Journal:  Can J Plast Surg       Date:  2013
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.